Needham & Company LLC Lowers CorMedix (NASDAQ:CRMD) Price Target to $12.00
CorMedix (NASDAQ:CRMD – Get Free Report) had its price target dropped by equities researchers at Needham & Company LLC from $18.00 to $12.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price objective points to a potential upside of 78.84% […]
CorMedix (NASDAQ:CRMD – Get Free Report) had its price target dropped by equities researchers at Needham & Company LLC from $18.00 to $12.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price objective points to a potential upside of 78.84% […]
